DZ Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Sell
27,670
-22,621
-45% -$1.24M ﹤0.01% 609
2025
Q1
$3.56M Buy
50,291
+13,494
+37% +$954K ﹤0.01% 479
2024
Q4
$2.42M Sell
36,797
-20,689
-36% -$1.36M ﹤0.01% 515
2024
Q3
$4.04M Buy
57,486
+41,845
+268% +$2.94M ﹤0.01% 473
2024
Q2
$1.29M Sell
15,641
-121,348
-89% -$9.99M ﹤0.01% 615
2024
Q1
$12M Buy
136,989
+7,023
+5% +$613K 0.01% 299
2023
Q4
$12.5M Sell
129,966
-21,421
-14% -$2.07M 0.02% 300
2023
Q3
$13.4M Buy
151,387
+56,011
+59% +$4.96M 0.02% 277
2023
Q2
$8.27M Sell
95,376
-37,398
-28% -$3.24M 0.01% 368
2023
Q1
$12.9M Sell
132,774
-75,292
-36% -$7.32M 0.02% 292
2022
Q4
$21.5M Buy
208,066
+14,281
+7% +$1.48M 0.04% 227
2022
Q3
$16.4M Buy
193,785
+40,806
+27% +$3.46M 0.03% 234
2022
Q2
$12.7M Buy
152,979
+28,323
+23% +$2.35M 0.02% 265
2022
Q1
$9.61M Buy
124,656
+6,914
+6% +$533K 0.01% 355
2021
Q4
$10.5M Sell
117,742
-2,969
-2% -$264K 0.01% 344
2021
Q3
$9.33M Buy
120,711
+13,319
+12% +$1.03M 0.01% 366
2021
Q2
$8.96M Buy
107,392
+42,538
+66% +$3.55M 0.01% 386
2021
Q1
$4.9M Hold
64,854
0.01% 446
2020
Q4
$5.65M Buy
64,854
+24,854
+62% +$2.16M 0.01% 392
2020
Q3
$3.04M Hold
40,000
0.01% 417
2020
Q2
$4.93M Hold
40,000
0.01% 340
2020
Q1
$3.38M Hold
40,000
0.01% 358
2019
Q4
$3.38M Hold
40,000
0.01% 405
2019
Q3
$2.7M Hold
40,000
0.01% 413
2019
Q2
$3.43M Hold
40,000
0.01% 411
2019
Q1
$3.55M Buy
40,000
+10,000
+33% +$888K 0.01% 392
2018
Q4
$2.51M Buy
+30,000
New +$2.51M 0.01% 425
2018
Q3
Sell
-30,000
Closed -$2.83M 755
2018
Q2
$2.83M Sell
30,000
-75,200
-71% -$7.08M 0.01% 448
2018
Q1
$8.53M Buy
105,200
+75,200
+251% +$6.1M 0.03% 313
2017
Q4
$2.68M Buy
+30,000
New +$2.68M 0.01% 439